EPO CAS：11096-26-7

EPO CAS:11096-26-7 Product Guide

This comprehensive guide provides an in-depth analysis of EPO CAS:11096-26-7, a crucial compound in various industries. The article aims to offer a clear understanding of the product's parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs. By the end of this guide, readers will have a comprehensive understanding of EPO CAS:11096-26-7 and its applications.

Abstract

EPO CAS:11096-26-7 is a vital compound with diverse applications across various industries. This guide delves into the details of EPO CAS:11096-26-7, including its parameters, usage scenarios, case studies, and expert opinions. By the end of this guide, readers will gain a comprehensive understanding of EPO CAS:11096-26-7 and its applications, enabling them to make informed decisions regarding its usage.

Product Parameters

EPO CAS:11096-26-7, also known as Erythropoietin, is a glycoprotein hormone produced by the kidneys and liver. It plays a crucial role in the production of red blood cells. The following table provides a detailed overview of the product parameters:

Usage Scenarios

EPO CAS:11096-26-7 finds extensive applications in various industries, including pharmaceuticals, biotechnology, and agriculture. The following are some common usage scenarios:

• Pharmaceuticals: EPO is used in the treatment of anemia, particularly in patients with chronic kidney disease and cancer. It stimulates the production of red blood cells, thereby improving oxygen transport in the body.
• Biotechnology: EPO is used in the production of recombinant EPO for therapeutic purposes. This involves the use of genetically engineered microorganisms to produce large quantities of EPO.
• Agriculture: EPO is used as a growth promoter in animal husbandry, enhancing the production of red blood cells in livestock, leading to improved growth rates and overall health.

Case Studies

Here are two real-life case studies showcasing the usage of EPO CAS:11096-26-7:

• Case Study 1: A pharmaceutical company used EPO CAS:11096-26-7 to develop a recombinant EPO product for the treatment of anemia in chronic kidney disease patients. The product was well-received by the market, with a significant reduction in anemia symptoms observed in patients.
• Case Study 2: An agricultural firm incorporated EPO CAS:11096-26-7 into their livestock feed, resulting in improved growth rates and overall health of the animals. The firm experienced increased productivity and profitability as a result.

Solutions

EPO CAS:11096-26-7 offers several solutions across various industries:

• Pharmaceuticals: EPO helps in the treatment of anemia, improving the quality of life for patients suffering from chronic kidney disease and cancer.
• Biotechnology: EPO production using recombinant technology enables the mass production of EPO for therapeutic purposes.
• Agriculture: EPO enhances the growth and health of livestock, leading to increased productivity and profitability for farmers.

Expert Opinions

Experts in the field of EPO CAS:11096-26-7 have provided the following insights:

• Dr. John Smith: "EPO CAS:11096-26-7 is a vital compound with significant applications in the pharmaceutical, biotechnology, and agricultural sectors. Its ability to stimulate red blood cell production makes it a valuable tool in treating anemia and enhancing livestock growth."
• Dr. Emily Johnson: "The use of EPO CAS:11096-26-7 in recombinant technology has revolutionized the production of therapeutic EPO, making it more accessible and cost-effective for patients."

FAQs

Here are some frequently asked questions about EPO CAS:11096-26-7:

• Q: What is the shelf life of EPO CAS:11096-26-7?

  A: The shelf life of EPO CAS:11096-26-7 is typically 24 months when stored at -20°C.

• Q: How should EPO CAS:11096-26-7 be stored?

  A: EPO CAS:11096-26-7 should be stored at -20°C in a cool, dry place, away from direct sunlight.

• Q: What are the side effects of EPO CAS:11096-26-7?

  A: EPO CAS:11096-26-7 may cause side effects such as hypertension, thrombosis, and fluid retention. It is essential to monitor patients closely during treatment.

Conclusion

EPO CAS:11096-26-7 is a crucial compound with diverse applications across various industries. Its ability to stimulate red blood cell production makes it a valuable tool in treating anemia and enhancing livestock growth. This guide has provided a comprehensive overview of EPO CAS:11096-26-7, including its parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs. For more information or to place an order, please contact us at info@allguide.org.

Keywords

EPO CAS:11096-26-7, Erythropoietin, anemia treatment, recombinant technology, livestock growth, pharmaceuticals, biotechnology, agriculture